Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Filomena Calabrese"'
Autor:
Antonio Avallone, Maria Carmela Piccirillo, Elena Di Gennaro, Carmela Romano, Filomena Calabrese, Maria Serena Roca, Fabiana Tatangelo, Vincenza Granata, Antonio Cassata, Ernesta Cavalcanti, Nicola Maurea, Piera Maiolino, Lucrezia Silvestro, Alfonso De Stefano, Francesco Giuliani, Gerardo Rosati, Emiliano Tamburini, Pasquale Aprea, Valeria Vicario, Anna Nappi, Carlo Vitagliano, Rossana Casaretti, Alessandra Leone, Antonella Petrillo, Gerardo Botti, Paolo Delrio, Francesco Izzo, Francesco Perrone, Alfredo Budillon
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Despite effective treatments, metastatic colorectal cancer (mCRC) prognosis is still poor, mostly in RAS -mutated tumors, thus suggesting the need for novel combinatorial therapies. Epigenetic alterations play an important role in initiat
Externí odkaz:
https://doaj.org/article/3eb026fee6a04fa2a16807978c679bff
Autor:
Claudia Cardone, Vincenzo Sforza, Antonio Avallone, Anna Nappi, Vincenzo Montesarchio, Francesca Andreozzi, Maria Biglietto, Filomena Calabrese, Roberto Bordonaro, Stefano Cordio, Giacomo Bregni, Antonio Febbraro, Rocio Garcia-Carbonero, Jaime Feliu
Publikováno v:
ESMO Open, Vol 4, Iss 4 (2019)
Background In patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC), the role of maintenance therapy after first-line treatment with chemotherapy plus antiepidermal growth factor receptor (EGFR) monoclonal antibodies (MoAb) is still an
Externí odkaz:
https://doaj.org/article/25737148f9664ae5b938984e5084ce09
Autor:
Paola Capodanno, Mariadelina Simeoni, Anna Maria Piscopo, Giovambattista Capasso, Ernesta Cavalcanti, Arturo Cuomo, Sofia Giuliana, Michelino De Laurentiis, Claudia von Arx, Matilde Pensabene, Filomena Calabrese
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background Malignant hypercalcemia is a common complication in cancer patients and can be predictive of poor prognosis and advanced malignancy. Cancer-related mechanisms of hypercalcemia depends either on ectopic hypersecretion of humoral factors (PT
Autor:
María Roca, Emiliano Tamburini, Rossana Casaretti, Maria Carmela Piccirillo, Nicola Maurea, Antonella Petrillo, Paolo Delrio, Antonio Avallone, Lucrezia Silvestro, A. Cassata, Anna Nappi, Carmela Romano, Alfredo Budillon, Gerardo Botti, Carlo Vitagliano, Pasquale Aprea, Fabiana Tatangelo, Francesco Giuliani, Francesco Perrone, Alfonso De Stefano, Filomena Calabrese, Ernesta Cavalcanti, Piera Maiolino, Valeria Vicario, Francesco Izzo, Gerardo Rosati, Alessandra Leone, Vincenza Granata, Elena Di Gennaro
Publikováno v:
Therapeutic Advances in Medical Oncology
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background:Despite effective treatments, metastatic colorectal cancer (mCRC) prognosis is still poor, mostly in RAS-mutated tumors, thus suggesting the need for novel combinatorial therapies. Epigenetic alterations play an important role in initiatio
Autor:
Filomena Calabrese, Carlo Molino, Vincenzo Sforza, Giovanni Conzo, Annalisa Pappalardo, Angelica Petrillo, Luca Pompella, Maria Maddalena Laterza, M. Biglietto, Michele Orditura, Marianna Caterino, Ferdinando De Vita, Vega Iranzo, Jole Ventriglia, Giuseppe Tirino, Fortunato Ciardiello
Publikováno v:
Journal of Gastrointestinal Oncology
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia
instname
Background: Nab-paclitaxel plus gemcitabine represents one of the standard regimens for first line treatment of metastatic pancreatic cancer (mPC). Few data are available on nab-paclitaxel plus gemcitabine in geriatric population. Our study aims to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e78aab724c76f1c740ab984c50752597
https://europepmc.org/articles/PMC6776800/
https://europepmc.org/articles/PMC6776800/
Autor:
M. Biglietto, Jaime Feliu, Claudia Cardone, Rocio Garcia-Carbonero, Andrés Cervantes, Roberto Bordonaro, F Andreozzi, Erika Martinelli, Giacomo Bregni, Teresa Troiani, Vincenzo Sforza, Fortunato Ciardiello, Antonio Avallone, Filomena Calabrese, Antonio Febbraro, Stefano Cordio, Vincenzo Montesarchio, Anna Nappi
Publikováno v:
ESMO Open, Vol 4, Iss 4 (2019)
ESMO Open
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Esmo Open
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
ESMO Open
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Esmo Open
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Background In patients with RAS wild-type (WT) metastatic colorectal cancer (mCRC), the role of maintenance therapy after first-line treatment with chemotherapy plus antiepidermal growth factor receptor (EGFR) monoclonal antibodies (MoAb) is still an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99f915700d312be344fe71b4b9a95d3f
https://hdl.handle.net/10486/690855
https://hdl.handle.net/10486/690855
Autor:
Giovanni Conzo, Filomena Calabrese, Angelica Petrillo, Ferdinando De Vita, M. Biglietto, Maria Maddalena Laterza, Carlo Molino, Fortunato Ciardiello, Marianna Caterino, Annalisa Pappalardo, Giuseppe Tirino, Anna Ventriglia, Michele Orditura, Luca Pompella
Publikováno v:
Medical oncology (Northwood, London, England). 36(10)
Nab-paclitaxel plus gemcitabine (Nab-Gem) represents one of the standard regimen for first-line treatment of metastatic pancreatic adenocarcinoma (mPDAC). However, few data are available in mPDAC relapsed after gemcitabine as adjuvant treatment. Our
Autor:
Filomena Calabrese
Publikováno v:
Comparative History of Literatures in European Languages
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c10d22f4ba83dbdaad668e8298819d92
https://doi.org/10.1075/chlel.xxx.40cal
https://doi.org/10.1075/chlel.xxx.40cal
Publikováno v:
Confraternitas. 26:25-27
Autor:
Filomena Calabrese
Publikováno v:
Quaderni d'italianistica. 32:75-100
In the period 1490-99, Leonardo da Vinci (1452-1519) wrote nearly three hundred literary writings that were later compiled by scholars into four primary collections: the Bestiario, Favole, Facezie, and Profezia. This article takes Leonardo’s Profez